Myotonia induced with clofibrate in rats

Area of Science:

• Pharmacology
• Neuroscience
• Muscle Physiology

Background:

• Myotonia is a disorder characterized by delayed muscle relaxation.
• Drug-induced myotonia models are crucial for understanding disease mechanisms and testing therapeutics.

Purpose of the Study:

• To investigate the effects of clofibrate on inducing myotonia in rats.
• To explore the underlying mechanisms of clofibrate-induced myotonia.
• To evaluate potential therapeutic agents for myotonia.

Main Methods:

• Rats were administered daily subcutaneous injections of clofibrate (0.4 g/kg).
• Electromyography was used to record myotonic discharges from various muscles.
• Repetitive nerve and direct muscle stimulation were employed to assess muscle electrical responses.
• Various drugs were tested for their efficacy in inhibiting myotonia, with diphenylhydantoin being a focus.
• Electrocardiogram (ECG) abnormalities were monitored in rats on a long-term clofibrate regimen.

Main Results:

• Clofibrate successfully induced myotonia in multiple rat muscles, with varying onset times.
• Myotonic activity was also observed in chronically denervated muscle, suggesting a direct muscle defect.
• Muscle electrical responses declined during repetitive stimulation, indicating a myotonic defect.
• Diphenylhydantoin demonstrated significant inhibition of clofibrate-induced myotonia.
• Extended clofibrate administration led to ECG abnormalities similar to those in human myotonic dystrophy.

Conclusions:

• Clofibrate serves as an effective agent for inducing myotonia in a rat model.
• The study suggests a myotonic defect within the muscle itself as the cause of clofibrate-induced myotonia.
• Diphenylhydantoin shows promise as a potential treatment for myotonia.
• This rat model may offer valuable insights into the pathophysiology and treatment of myotonic dystrophy.